We are live on ! Find out more
CRVO icon

CervoMed
CRVO

11 hedge funds and large institutions have $417K invested in CervoMed in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.08% more ownership

Funds ownership: 0.01% → 0.08% (+0.08%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

35% less funds holding

Funds holding: 17 → 11 (-6)

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

76% less capital invested

Capital invested by funds: $1.76M → $417K (-$1.34M)

Holders
11
Holders Change
-6
Holders Change %
-35.29%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
3
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
+$151K
2
Two Sigma Investments
Two Sigma Investments
New York
+$146K
3
Renaissance Technologies
Renaissance Technologies
New York
+$138K
4
VF
Virtu Financial
New York
+$70.9K
5
Citadel Advisors
Citadel Advisors
Florida
+$60.4K

Top Sellers

Rank Fund Capital Flow
1
SRCM
Swift Run Capital Management
Virginia
-$646K
2
Millennium Management
Millennium Management
New York
-$100K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$71.6K
4
Goldman Sachs
Goldman Sachs
New York
-$28K
5
TSS
Two Sigma Securities
New York
-$20K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$103K +$138K +405 +142%
Vanguard Group
2
Vanguard Group
Pennsylvania
$87K -$71.6K -210 -26%
AFM
3
Anson Funds Management
Texas
$66K +$151K +442 New
Two Sigma Investments
4
Two Sigma Investments
New York
$64K +$146K +429 New
VF
5
Virtu Financial
New York
$37K +$70.9K +208 +562%
SRCM
6
Swift Run Capital Management
Virginia
$29K -$646K -1,893 -91%
Citadel Advisors
7
Citadel Advisors
Florida
$26K +$60.4K +177 New
UBS Group
8
UBS Group
Switzerland
$3K -$2.05K -6 -21%
PNC Financial Services Group
9
PNC Financial Services Group
Pennsylvania
$1K – – –
Citigroup
10
Citigroup
New York
$1K +$2.39K +7 New
Millennium Management
11
Millennium Management
New York
– -$100K -205 Closed
Goldman Sachs
12
Goldman Sachs
New York
– -$28K -57 Closed
TSS
13
Two Sigma Securities
New York
– -$20K -40 Closed
Northern Trust
14
Northern Trust
Illinois
– -$13K -27 Closed
Jane Street
15
Jane Street
New York
– -$8K -17 Closed
SFM
16
Signature Financial Management
Virginia
– -$5K -11 Closed
SCM
17
Sterling Capital Management
North Carolina
– -$4K -9 Closed
WTC
18
WhitTier Trust Company
Nevada
– -$3K -6 Closed
AG
19
Advisor Group
Arizona
– -$2K -4 Closed
JA
20
JOYN Advisors
Georgia
– -$1K -2 Closed

CRVO Hedge Fund Activity: Q4 2018 in Review

11 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q4 2018, worth a combined $417K — down 76% from $1.76M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of CRVO and 4 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $151K. The largest seller was Swift Run Capital Management, cutting an estimated $646K.

  • 11 institutional investors held CervoMed (CRVO) as of Q4 2018, down from 17 in Q3 2018.
  • Funds reported $417K of CervoMed stock for Q4 2018, down 76% quarter-over-quarter.
  • 4 funds opened new CervoMed positions in Q4 2018 and 10 closed out, a net change of -6 holders.
  • The largest CervoMed buyer in Q4 2018 was Anson Funds Management, an estimated $151K added.
  • The largest CervoMed seller in Q4 2018 was Swift Run Capital Management, an estimated $646K sold.

Based on aggregated 13F filings for Q4 2018.